Total global sales of Allergan's Botox 2017 vs. 2024 forecast

Allergan is a global pharmaceutical company most well known for their drug Botox, an injectable drug used in the treatment of muscle spasms and in some cosmetic procedures. As of 2017, about 3.2 billion U.S. dollars worth of Botox was sold globally. It is estimated that sales of Botox will increase to about 4.6 billion U.S. dollars by the year 2024. Botox is primarily sold in the United States with the international market accounting for significantly less sales.

Allergan’s company profile

Allergan is a multinational company with operations in around 100 countries globally. The company is headquartered in Dublin, Ireland. Allergan’s revenues have been increasing in recent years, indicating increasing successes for the company. Of the many segments of Allergan’s operations, the U.S. specialized therapeutics segment has earned the company the most revenue in recent years.

Other Allergan products

Allergan has several products that are leading the company’s revenues. Botox therapeutics, Restasis and Botox Cosmetics were among the company’s top U.S. products based on revenue. Within these categories Allergan has several products used in a variety of treatments including Juvederm and Coolsculpting, to name two. Among all therapeutic areas that the company works in, medical aesthetics and eye care were the largest revenue generators for Allergan in 2018.